References

Evaluation and management of chronic kidney disease: synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline

10.7326/0003-4819-158-11-201306040-00007 · 2013 · External reference

Hypertension in chronic kidney disease: What lies behind the scene

2022 · External reference

Recent advances in diabetic kidney disease

10.1186/s12916-021-02050-0 · 2021 · External reference

The vulnerable patient with chronic kidney disease

10.1093/ndt/gfv041 · 2016 · External reference

Microvascular dysfunction and kidney disease: Challenges and opportunities

10.1111/micc.12661 · 2020 · External reference

Skin microvascular function and renal hemodynamics in overweight patients with type 2 diabetes: A cross-sectional study

10.1111/micc.12700 · 2021 · External reference

Microcirculation in hypertension: A therapeutic target to prevent cardiovascular disease?

10.3390/jcm12154892 · 2023 · External reference

Endothelial dysfunction and hypertension

10.1007/5584_2016_90 · 2017 · External reference

Role of Uremic Toxins in Vascular Inflammation Associated with Chronic Kidney Disease

10.3390/jcm13237149 · 2024 · External reference

Mechanistic insights into CKD‑MBD‑related vascular calcification

10.1016/j.lfs.2022.121148 · 2022 · External reference

Renal vascular structure and rarefaction

10.1002/j.2040-4603.2013.tb00504.x · 2013 · External reference

Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease

10.1007/s00467-013-2430-y · 2014 · External reference

Evaluation of the microcirculation in hypertension and cardiovascular disease

10.1093/eurheartj/ehm448 · 2007 · External reference

Assessing skin microcirculation in patients at cardiovascular risk by using laser speckle contrast imaging. A narrative review

10.1111/cpf.12819 · 2023 · External reference

Commentary on viewpoint: the human cutaneous circulation as a model of generalized microvascular function

10.1152/japplphysiol.90345.2008 · 2008 · External reference

Ageing and microvasculature

10.1186/2045-824x-6-19 · 2014 · External reference

Microcirculatory function deteriorates with advancing stages of chronic kidney disease independently of arterial stiffness and atherosclerosis

2020 · External reference

Microcirculation of the fingernail fold in CAPD patients: preliminary observations

10.1177/089686089601600416 · 1996 · External reference

Capillary rarefaction in advanced chronic kidney disease is associated with high phosphorus and bicarbonate levels

10.1093/ndt/gfr089 · 2011 · External reference

Capillary rarefaction: An early marker of microvascular disease in young hemodialysis patients

10.1093/ckj/sfu106 · 2014 · External reference

Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects

10.1161/01.res.86.12.1198 · 2000 · External reference

Elevated risk of stroke among patients with end-stage renal disease

10.1046/j.1523-1755.2003.00101.x · 2003 · External reference

Risks of adverse events in advanced CKD: The chronic renal insufficiency cohort (CRIC) Study

10.1053/j.ajkd.2017.01.050 · 2017 · External reference

Chronic kidney disease and cardiovascular disease in the Medicare population

2003 · External reference

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts

10.1038/ki.2010.536 · 2011 · External reference

Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure

10.1152/ajpheart.00287.2004 · 2004 · External reference

Inflammation and angiotensin II

10.1016/s1357-2725(02)00271-6 · 2003 · External reference

Vascular endothelial cell injury: Causes, molecular mechanisms, and treatments

2025 · External reference

Association of kidney function with changes in the endothelial surface layer

10.2215/cjn.08160813 · 2014 · External reference

Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines

10.1093/ndt/16.6.1189 · 2001 · External reference

Myocardial involvement in end-stage renal disease patients with anemia as assessed by cardiovascular magnetic resonance native T1 mapping: An observational study

10.1097/md.0000000000039724 · 2024 · External reference

Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study

10.1186/s12882-023-03133-1 · 2023 · External reference

Pathophysiological concepts and screening of cardiovascular disease in dialysis patients

2021 · External reference

The red blood cell as an oxygen sensor: What is the evidence?

10.1046/j.1365-201x.2000.00708.x · 2000 · External reference

Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation

10.1038/nm954 · 2003 · External reference

S-nitrosohaemoglobin: A dynamic activity of blood involved in vascular control

10.1038/380221a0 · 1996 · External reference

A molecular perspective on HIF‑1α and angiogenic stimulator networks and their role in solid tumors: An update

10.3390/ijms25063313 · 2024 · External reference

The distinct role of HIF‑1α and HIF‑2α in hypoxia and angiogenesis

10.3390/cells14090673 · 2025 · External reference

Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: Applications and therapies

10.1155/2015/549412 · 2015 · External reference